Citigroup Inc. (C) Stock Price Today
Dimensional Fund Advisors reduces stake in Beazley PLC by selling 730,460 shares.
Dimensional Fund Advisors Ltd disclosed a sale of 730,460 ordinary shares of Beazley PLC, reducing its holding to 0.89% as of June 30, 2026. This transaction reflects a partial exit from their investment in Beazley PLC. The sale price per share was a...
Global pyrometer market to double to $1.15B by 2035, driven by industrial automation and semiconductor growth
The global pyrometer market, valued at $544.55 million in 2025, is projected to reach $1.15 billion by 2035, growing at a CAGR of 7.57%. This growth is fueled by rising industrial automation and expansion in semiconductor manufacturing, which increas...
Ocugen to present gene therapy advances at July 2026 industry conferences
Ocugen, a biotech leader in gene therapies for blindness, announced it will showcase its innovative modifier gene therapy platform at several investor and industry conferences in July 2026. Presentations will cover clinical trial results and regenera...
Deadlines set for lead plaintiff appointments in class action lawsuits against BitGo, ADMA Biologics, and Erasca.
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against BitGo Holdings, ADMA Biologics, and Erasca. The lawsuits allege these companies made false or misleading statements affe...
Investec Bank discloses share dealings for Advanced Medical Solutions Group on June 30, 2026
Investec Bank plc, acting as advisor and joint broker to Advanced Medical Solutions Group plc, disclosed its share dealings on June 30, 2026. The bank purchased 1,252,666 ordinary shares and sold 1,302,983 ordinary shares at prices between 279.5 and ...
BETR investors invited to join fraud probe after shares plunge 28.5% on Q1 earnings call
The Schall Law Firm is investigating Better Home & Finance Holding Company (BETR) for potential securities law violations after the company reported strong Q1 2026 results but warned of borrower hesitancy due to high interest rates. Following the ear...
Law firm investigates Phreesia directors for possible fiduciary breaches before May 2025.
Bernstein Liebhard LLP is investigating whether certain directors and officers of Phreesia, Inc. breached their fiduciary duties to the company. The investigation targets shares purchased before May 8, 2025. Shareholders who own Phreesia stock and wa...
Bernstein Liebhard investigates Babcock & Wilcox for possible fiduciary breaches before Nov 2025.
Bernstein Liebhard LLP is investigating whether certain directors and officers of Babcock & Wilcox Enterprises, Inc. breached their fiduciary duties to the company. The investigation targets shareholders who purchased stock before November 5, 2025. I...
Bernstein Liebhard investigates SES AI Corp for possible fiduciary breaches before Jan 2025.
Bernstein Liebhard LLP is investigating SES AI Corporation for potential breaches of fiduciary duties by its directors and officers related to actions before January 29, 2025. The law firm invites current SES AI shareholders who purchased stock befor...
Three biotechs show promising clinical data and AI advances, driving key catalysts in H2 2026.
Can-Fite BioPharma reported positive Phase 2a pancreatic cancer trial results with Namodenoson, showing safety and survival benefits, and plans a Phase 2b combo study. NeOnc Technologies is awaiting Phase 2a data for NEO100 with FDA designations and ...